Teehan Brendan
SEC CIK 1891900 · EDGAR
BoughtSold
Most active insiders at PCRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Cross Shawn | CFO | — | $1.52M |
| 2 | WILLIAMS KRISTEN | Chief Administrative Off | — | $498.2K |
| 3 | RIKER LAUREN | SVP, Fin | — | $261.3K |
| 4 | SLONIN JONATHAN | Chief Medical Off | — | $240.4K |
| 5 | Froimson Mark | Dir | — | $10.9K |
| 6 | BIGAL MARCELO | Dir | — | — |
| 7 | Young Alethia | Dir | — | — |
| 8 | Teehan Brendan | Chief Commercial Off | — | — |
| 9 | Lee Frank D. | CEO, Dir | — | — |
| 10 | CHRISTIE CHRISTOPHER | Dir | — | — |
Transactions 36
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-13 | 2026-02-11 | PCRX | Pacira BioSciences, Inc. | Teehan Brendan | Chief Commercial Off | A - Grant | $0.00 | +51.7K | 100.9K | +105% | $0 | |
| 2026-02-03 | 2026-01-30 | PCRX | Pacira BioSciences, Inc. | Teehan Brendan | Chief Commercial Off | F - Tax | $20.54 | -5,182 | 49.2K | -10% | -$106.4K | |
| 2026-01-06 | 2025-12-31 | PCRX | Pacira BioSciences, Inc. | Teehan Brendan | Chief Commercial Off | A - Grant | $10.76 | +402.27 | 54.4K | +0.7% | +$4,328 | |
| D | 2025-02-04 | 2025-02-01 | PCRX | Pacira BioSciences, Inc. | Teehan Brendan | Chief Commercial Off | A - Grant | $0.00 | +54.0K | 54.0K | New | $0 |
| DM | 2024-11-19 | 2024-11-17 | ACAD | ACADIA PHARMACEUTICALS INC | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | M - OptEx | — | +19.8K | 62.5K | +46% | — |
| D | 2024-11-19 | 2024-11-19 | ACAD | ACADIA PHARMACEUTICALS INC | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | S - Sale+OE | $16.81 | -10.3K | 62.1K | -14% | -$173.6K |
| 2024-08-20 | 2024-08-19 | ACAD | ACADIA PHARMACEUTICALS INC | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | S - Sale | $15.28 | -9,534 | 52.2K | -15% | -$145.7K | |
| M | 2024-08-20 | 2024-08-16 | ACAD | ACADIA PHARMACEUTICALS INC | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | A - Grant | $0.00 | +18.7K | 61.7K | +43% | $0 |
| D | 2024-05-03 | 2024-05-02 | ACAD | ACADIA PHARMACEUTICALS INC | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | S - Sale+OE | $16.94 | -3,477 | 42.1K | -8% | -$58.9K |
| D | 2024-05-03 | 2024-05-01 | ACAD | ACADIA PHARMACEUTICALS INC | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | M - OptEx | — | +6,814 | 45.6K | +18% | — |
| D | 2024-04-09 | 2024-04-05 | ACAD | ACADIA PHARMACEUTICALS INC | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | M - OptEx | — | +5,024 | 41.4K | +14% | — |
| D | 2024-04-09 | 2024-04-08 | ACAD | ACADIA PHARMACEUTICALS INC | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | S - Sale+OE | $17.87 | -2,568 | 38.8K | -6% | -$45.9K |
| D | 2024-03-27 | 2024-03-25 | ACAD | ACADIA PHARMACEUTICALS INC | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | A - Grant | $0.00 | +10.0K | 41.5K | +32% | $0 |
| D | 2024-03-27 | 2024-03-27 | ACAD | ACADIA PHARMACEUTICALS INC | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | S - Sale | $17.90 | -5,140 | 36.3K | -12% | -$92.0K |
| D | 2024-02-27 | 2024-02-23 | ACAD | ACADIA PHARMACEUTICALS INC | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | M - OptEx | — | +1,107 | 32.1K | +4% | — |
| D | 2024-02-27 | 2024-02-26 | ACAD | ACADIA PHARMACEUTICALS INC | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | S - Sale+OE | $24.67 | -624 | 31.4K | -2% | -$15.4K |
| D | 2024-01-09 | 2024-01-08 | ACAD | ACADIA PHARMACEUTICALS INC | Teehan Brendan | EVP, COO, Head of Commercial | S - Sale+OE | $29.96 | -731 | 30.9K | -2% | -$21.9K |
| D | 2024-01-09 | 2024-01-06 | ACAD | ACADIA PHARMACEUTICALS INC | Teehan Brendan | EVP, COO, Head of Commercial | M - OptEx | — | +1,287 | 31.7K | +4% | — |
| DM | 2023-11-21 | 2023-11-17 | ACAD | ACADIA PHARMACEUTICALS INC | Teehan Brendan | EVP, COO, Head of Commercial | M - OptEx | — | +9,912 | 35.4K | +39% | — |
| D | 2023-11-21 | 2023-11-20 | ACAD | ACADIA PHARMACEUTICALS INC | Teehan Brendan | EVP, COO, Head of Commercial | S - Sale+OE | $22.64 | -4,960 | 30.4K | -14% | -$112.3K |
| DM | 2023-05-19 | 2023-05-17 | ACAD | ACADIA PHARMACEUTICALS INC | Teehan Brendan | EVP, COO, Head of Commercial | M - OptEx | — | +29.7K | 24.4K | New | — |
| D | 2023-05-19 | 2023-05-17 | ACAD | ACADIA PHARMACEUTICALS INC | Teehan Brendan | EVP, COO, Head of Commercial | S - Sale+OE | $22.50 | -14.9K | 24.4K | -38% | -$334.6K |
| D | 2023-05-02 | 2023-04-29 | ACAD | ACADIA PHARMACEUTICALS INC | Teehan Brendan | EVP, COO, Head of Commercial | M - OptEx | $0.00 | +1,567 | 10.0K | +19% | $0 |
| D | 2023-05-02 | 2023-05-01 | ACAD | ACADIA PHARMACEUTICALS INC | Teehan Brendan | EVP, COO, Head of Commercial | S - Sale+OE | $21.18 | -548 | 9,487 | -5% | -$11.6K |
| D | 2023-04-07 | 2023-04-06 | ACAD | ACADIA PHARMACEUTICALS INC | Teehan Brendan | EVP, COO, Head of Commercial | S - Sale+OE | $18.16 | -1,751 | 8,468 | -17% | -$31.8K |
| D | 2023-04-07 | 2023-04-05 | ACAD | ACADIA PHARMACEUTICALS INC | Teehan Brendan | EVP, COO, Head of Commercial | M - OptEx | — | +5,024 | 10.2K | +97% | — |
| D | 2023-02-27 | 2023-02-24 | ACAD | ACADIA PHARMACEUTICALS INC | Teehan Brendan | EVP, COO, Head of Commercial | S - Sale+OE | $18.78 | -461 | 5,195 | -8% | -$8,658 |
| D | 2023-02-27 | 2023-02-23 | ACAD | ACADIA PHARMACEUTICALS INC | Teehan Brendan | EVP, COO, Head of Commercial | M - OptEx | — | +1,107 | 5,656 | +24% | — |
| D | 2023-01-10 | 2023-01-09 | ACAD | ACADIA PHARMACEUTICALS INC | Teehan Brendan | EVP, COO, Head of Commercial | S - Sale+OE | $17.13 | -532 | 4,549 | -10% | -$9,113 |
| D | 2023-01-10 | 2023-01-06 | ACAD | ACADIA PHARMACEUTICALS INC | Teehan Brendan | EVP, COO, Head of Commercial | M - OptEx | — | +1,286 | 5,081 | +34% | — |
| D | 2022-05-03 | 2022-05-02 | ACAD | ACADIA PHARMACEUTICALS INC | Teehan Brendan | EVP, COO, Head of Commercial | S - Sale+OE | $18.18 | -552 | 3,437 | -14% | -$10.0K |
| D | 2022-05-03 | 2022-04-29 | ACAD | ACADIA PHARMACEUTICALS INC | Teehan Brendan | EVP, COO, Head of Commercial | M - OptEx | — | +1,567 | 3,989 | +65% | — |
| D | 2022-02-25 | 2022-02-23 | ACAD | ACADIA PHARMACEUTICALS INC | Teehan Brendan | EVP, COO, Head of Commercial | S - Sale+OE | $23.80 | -472 | 2,422 | -16% | -$11.2K |
| D | 2022-02-25 | 2022-02-23 | ACAD | ACADIA PHARMACEUTICALS INC | Teehan Brendan | EVP, COO, Head of Commercial | M - OptEx | $0.00 | +1,106 | 2,894 | +62% | $0 |
| D | 2022-01-10 | 2022-01-06 | ACAD | ACADIA PHARMACEUTICALS INC | Teehan Brendan | EVP, COO, Head of Commercial | S - Sale+OE | $23.05 | -538 | 1,788 | -23% | -$12.4K |
| D | 2022-01-10 | 2022-01-06 | ACAD | ACADIA PHARMACEUTICALS INC | Teehan Brendan | EVP, COO, Head of Commercial | M - OptEx | — | +1,286 | 2,326 | +124% | — |
Purchase Sale Sale after option exercise All abbreviations